Corient Capital Partners, LLC Abb Vie Inc. Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Corient Capital Partners, LLC holds 96,108 shares of ABBV stock, worth $16.4 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

96,108

Previous 96,108 -0.0%

Holding current value

$16.4 Million

Previous $14.7 Million -0.0%

% of portfolio

1.1%

Previous 1.12%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$137.62 - $174.96 $26,285 - $33,417	191 Added 0.2%	96,108 $14.7 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $867,900 - $1.08 Million	6,576 Added 7.36%	95,917 $15.5 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $320,678 - $405,751	2,985 Added 3.46%	89,341 $12.1 Million
Q3 2021 Nov 16, 2021	SELL	$106.4 - $120.78 $340,480 - $386,496	-3,200 Reduced 3.57%	86,356 $9.32 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $1.45 Million - $1.62 Million	13,799 Added 18.21%	89,556 $10.1 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $200,610 - $220,847	1,961 Added 2.66%	75,757 $8.2 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $329,365 - $444,677	4,092 Added 5.87%	73,796 $7.91 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $97,078 - $113,937	1,130 Added 1.65%	69,704 $6.11 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $971,638 - $1.3 Million	13,243 Added 23.93%	68,574 $6.73 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $850,561 - $1.29 Million	13,187 Added 31.29%	55,331 $4.22 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $117,283 - $146,746	1,626 Added 4.01%	42,144 $3.73 Million
Q3 2019 Nov 06, 2019	BUY	$62.98 - $75.72 $52,462 - $63,074	833 Added 2.1%	40,518 $3.07 Million
Q2 2019 Aug 08, 2019	SELL	$65.7 - $83.98 $99,864 - $127,649	-1,520 Reduced 3.69%	39,685 $2.89 Million
Q1 2019 May 10, 2019	SELL	$77.14 - $90.79 $818,918 - $963,826	-10,616 Reduced 20.49%	41,205 $3.32 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $1 Million - $1.24 Million	-12,875 Reduced 19.9%	51,821 $4.78 Million
Q2 2018 Oct 02, 2018	BUY	$89.78 - $106.23 $231,093 - $273,436	2,574 Added 4.14%	64,696 $5.99 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $1.52 Million - $2.04 Million	-16,551 Reduced 21.04%	62,122 $5.88 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $1.52 Million - $1.67 Million	-17,008 Reduced 17.78%	78,673 $7.61 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $589,254 - $752,659	-8,436 Reduced 8.1%	95,681 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-1,514 Reduced 1.43%	104,117 $7.55 Million
Q1 2017 Aug 17, 2017	BUY	N/A	61,326 Added 138.42%	105,631 $6.88 Million
Q1 2017 Aug 14, 2017	BUY	N/A	44,305	44,305 $6.37 Million

Others Institutions Holding ABBV

# of Institutions

3,808

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.94M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Abb Vie Inc. Transaction History